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Abstract 
 
Intrauterine exposure to nicotine is one of the largest modifiable risk factors for infant 
morbidity and mortality. Previous progress toward decreasing the number impacted by 
intrauterine nicotine exposure has recently plateaued. While guidelines for assisting pregnant 
women to stop smoking are available, few providers have a formalized protocol in place. This 
project will evaluate most current research evidence regarding smoking cessation during 
pregnancy in order to develop a formalized protocol for implementation in an obstetric clinic in 
Southwest Ohio. Reviewed literature was summarized and level of evidence was established. 
Recommendations were made and categorized as strong, moderate, and weak.  The information 
was compiled into a formalized protocol with hand outs and disseminated to select obstetric 
providers in Southwest Ohio. 
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Smoking Cessation during Pregnancy: An Evidence Based Practice Protocol 
Chapter 1: Introduction 
Background 
Smoking during pregnancy is one of the largest modifiable risk factors for infant 
morbidity and mortality (Smoking cessation during pregnancy, 2011; Tong et al, 2013). Rates of 
smoking during pregnancy have decreased due to public health education and campaigns within 
the United States (ACOG, 2010). However, rates have plateaued over recent years.  In 2010, 
only 10.7 percent of women smoked during pregnancy (Tong et al, 2013) compared to nearly 42 
percent in 1990 across the United States (ACOG, 2010). Many of these women also work hard to 
quit smoking during pregnancy. The Morbidity and Mortality Weekly Report published by the 
Center for Disease Control and Prevention (CDC) shows approximately 55 percent of U.S. 
pregnant smokers quit during pregnancy (Tong et al, 2013), however approximately 40 percent 
relapse within six months postpartum (Tobacco use and pregnancy, 2014; Tong et al, 2013). 
Within Ohio, 47.2 percent of pregnant smokers quit smoking during pregnancy in 2010, with 22 
percent relapsing back to smoking after delivery (Tong et al, 2013). Both of these statistics show 
that a large number of women and babies are affected by smoking during pregnancy. Within 
Ohio, 16.5 – 21.6 percent of pregnant women smoked within the third trimester between 2000 
and 2010 (Tong et al, 2013). The lowest percentage, 16.5 percent occurred in 2010. However, 
just one year prior 21 percent of pregnant women smoked during pregnancy. The second lowest 
year occurred in 2000 at 17.1 percent (Tong et al, 2013). These statistics show that the rates in 
smoking cessation during pregnancy have plateaued in recent years. Therefore, the current 
methods of assisting pregnant patients to stop smoking are not affective. 
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Significance 
Smoking during pregnancy can cause unwanted effects to mother and fetus. During 
pregnancy, smoking causes decreased placental size and blood flow (Anblogan et al, 2013) 
which can cause placenta previa, abruptio placenta, and premature rupture of membranes (Castle 
et al, 1999; Shiozaki et al, 2011; Youngkin & Davis, 2013). Smoking any amount of cigarettes 
during pregnancy can lead to small for gestational age babies with decreases in birth weight, 
length, and head circumference (Batech et al, 2013; Gunnerbeck et al, 2011; Pickett et al, 2009; 
Roza, 2007; Ward, Lewis, & Coleman, 2007). Babies born to smoking mothers have an 
increased risk of low birth weight and preterm birth not only when compared to births of non-
smoking mothers, but they are also at significantly increased risk when compared to babies born 
to mothers who quit smoking during pregnancy (Batech et al, 2013).  Decreased organ size 
including brain, kidneys, and lungs in babies exposed to nicotine in utero has also been observed 
(Anblogan et al, 2013). These growing issues can continue after delivery as well. The newborn 
who was exposed to nicotine in utero continues to grow at decreased rates during through 
puberty (Fogelman & Manor, 1988). After delivery, newborns who were exposed to tobacco in 
utero suffered significantly more apnea episodes (Gunnerbeck et al, 2011). Adolescents born to 
mothers who smoked during pregnancy are more likely to have asthma (Shripak, 2014). As 
described above, smoking during pregnancy decreases health of baby and can negatively affect 
growth and development which leads to increased morbidity and mortality for infants exposed to 
smoke in utero. 
Problem 
Even with clear research evidence showing the damaging effects of smoking during 
pregnancy, many women’s health providers lack an evidence based practice protocol to address 
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this issue. Oak Creek Ob/Gyn currently does not have a formal protocol in place. Among their 
practitioners, all survey respondents reported advising their smoking pregnant patients to quit. 
Half of the respondents reported following ACOG guidelines and half reported not following any 
set guidelines (K.R. Ruhlman, personal communication, November, 2014). In Ohio, nearly all 
providers recognize the damaging effects of smoking and ask their pregnant patients about 
smoking (Jordan et al, 2006). However, after the initial inquiry, many do not assist their patients 
in taking steps to quit. The American College of Obstetrics and Gynecology (ACOG, 2010) has 
outlined a five step program for women’s health practitioners to assist their patients with 
smoking cessation.  However, only six percent of Ohio obstetric providers actually use this 
protocol to its full extent (Jordan et at, 2006). Looking outside of Ohio this trend continues. Dr. 
Chang and associates (2013) monitored obstetrics offices within the United States for 
implementation of the smoking cessation program suggested by ACOG at first antepartum visits. 
Within their study no practitioners ever used all five of the steps recommended by ACOG and 
only 21 percent used three or more of the steps at the first antepartum visit (Chang et al, 2013).  
Studies show obstetric providers do not feel adequately prepared to successfully assist their 
patients to stop smoking early in pregnancy (Kim et al, 2009). This lack in preparation can be 
due to inadequate education, lack of appropriate resources, or time constraints. Without a quick 
and easy to use tool with clinic based interventions available at providers’ finger tips, rates in 
smoking cessation are unlikely to change (Kim et al, 2009). 
Purpose 
Therefore, the purpose of this project is to evaluate research on smoking cessation during 
pregnancy and develop a quick, easy to use, evidence based practice protocol for implementation 
at Oak Creek OB/Gyn in southwest Ohio. 
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Chapter 2: Concept Analysis 
 In this section, the concept of smoking cessation assistance during pregnancy will be 
analyzed and operationally defined. The established operational definition for smoking cessation 
during pregnancy will help guide research on this topic and the development of an evidence 
based practice protocol.  
Use of the Concept 
  The concept of smoking cessation assistance is a nursing intervention from the Nursing 
Intervention Classification (Mosby’s dictionary of medicine, nursing, & health professions, 
2006) and is defined as “helping a patient stop smoking through individual or group process” 
(Bluecheck, 2013). However, smoking cessation assistance during pregnancy is a combined term 
and is not formally defined in literature. For this reason, this concept will be broken down into 
defining attributes. 
Defining Attributes 
Smoking cessation assistance during pregnancy is made up of three defining attributes 
including 1) current smoker, 2) attempting to stop smoking, and 3) pregnancy.  
Current smoker. Among current literature smoking status can be evaluated two ways 
including self-report (MMWR, 2011; Salmond et al, 2012; Dzubur, 2013; Patient Protection and 
Affordable Care Act, 2010) or biomedical testing (Melvin & Tucker, 2000). The CDC’s National 
Health Interview Survey (2009) used a self-report questionnaire to categorize interviewed US 
citizens as current smokers, former smokers, or never smoked. Those interviewed were asked, 
“Have you smoked at least 100 cigarettes in your entire life? (NHIS, 2009)” Those who 
answered, “yes” were asked, “Do you now smoke cigarettes every day, some days, or not at all? 
(NHIS, 2009)” Those who answered every day were considered current smokers while those 
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who answered “some days” were considered current smokers attempting to quit. Salmond and 
associates (2012) also asked interviewees to self-report smoking status by answering the 
question, “Do you smoke regularly (that is one or more cigarettes a day)? (Salmond et al, 2012, 
p. 665)” Melvin and Tucker (2000) used the same question proposed by the CDC, however they 
also suggested verifying these answers via biochemical testing including cotinine levels in urine 
or saliva or verify by measuring expired carbon monoxide. Cotinine is the main metabolite of 
nicotine and stays in the body significantly longer than nicotine (Cotinine, 2013). Because of 
this, cotinine levels are the gold standard for biochemically verifying smoking status (Cotinine, 
2013).  Melvin and Tucker (2000) further clarify the CDC’s second question by asking whether 
the interviewee has smoked at least once in the last seven days. Those who have smoked even a 
puff in the last seven days are considered current smokers. The Patient Protection and Affordable 
Care Act (2010) defines current smokers as those who have smoked four or more times in a 
week within the previous six months. For the sake of this project, a current smoker is someone 
who self-reports smoking 100 cigarettes in their life and has smoked at least once in the last 
seven days.  
Smoking cessation. Cessation of smoking means to temporarily or permanently stop 
smoking (Merriam-Webster, n.d.). Building off of the above definition of smoking, someone 
who has stopped smoking must not meet the definition of current smoker. Therefore they must 
have not smoked even once in the last seven days. Within currently literature there are two main 
ways to measure smoking cessation including 24 hour self-report (Catley et al, 2012; Etter 2009; 
Whitwell, 2011) or 7 days reported or verified smoke free (Catley et al, 2012; Chan et al, 2012; 
Winickoff et al, 2010) . Some studies use both of these measures with a higher percentage 
reporting smoke free for 24 hours compared to 7 days (Mason, Gilbert, & Sutton, 2012; Lycet, 
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Hajek, & Aveyard, 2010).  One study suggested that any self-reported quit attempt, even less 
than 24 hours should be included in the definition of smoking cessation (Hughes et al, 2010). In 
non-pregnant adults, the reason for smoking cessation assistance is to recognize quit attempts in 
order to aid the patient in moving along stages of change to ultimately reach sustained cessation 
(Cabezas et al, 2011; Chan et al, 2012; Kim et al, 2013; Prochaska & Velicer, 1997). However, 
no amount of nicotine is safe in pregnancy and one puff can cause some extent of harm to the 
fetus (ACOG, 2010). Because of this effect, the premise for recognizing cessation attempts is to 
minimize or eliminate nicotine exposure to the fetus. Therefore, a full seven day cessation is 
used to define smoking cessation in pregnancy. For the purpose of this paper, smoking cessation 
means the patient has not taken even one puff of a cigarette in the previous seven days. 
Pregnancy. Barnhart and associates (2010) published a review of literature for pregnancy 
definitions. They established formal operational definitions for intrauterine pregnancies, ectopic 
pregnancies, and pregnancies of undefined location. Since smoking cessation during pregnancy 
focuses on improving outcomes for both mother and unborn child, intrauterine pregnancies are of 
most interest. Barnhart and his associates (2010) define pregnancy based on transvaginal 
ultrasound. They identify intrauterine pregnancies as “intrauterine gestational sac with yolk sac 
and/or embryo (with or without cardiac activity). (Barhart et al, 2010, p 859)” While transvaginal 
ultrasound is the most sensitive way of positively diagnosing intrauterine pregnancy (Murray & 
McKinney, 2010; Youngkin & Davis, 2013), most uncomplicated pregnancies only receive an 
ultrasound at 18-22 weeks gestation (ACOG, 2013; Group health, 2013; United healthcare, n.d.; 
Youngkin et al, 2013). American College of Obstetricians and Gynecologists (ACOG,2013) calls 
for urine β-hcg level measurement to initially confirm pregnancy. Based off this standard 
established by ACOG, insurance companies will only pay for an ultrasound between 18-22 
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weeks unless signs of complications present prior (ACOG, 2013; Group health, 2013; Unite 
healthcare, n.d.). Another positive sign of pregnancy is auscultation of fetal heart tones through 
the abdomen (Murray & McKinney 2010; Youngkin et al, 2013). Fetal heart tones can initially 
be heard between eight and twelve weeks gestation (Murray & McKinney, 2010; Youngkin et al, 
2013). Many women present to the clinic for pregnancy confirmation earlier than eight weeks. 
ACOG guidelines recommend always confirming pregnancy with urine β-hcg in the office 
setting and if beyond 8 weeks of gestation, auscultate fetal heart tones (ACOG, 2013). Since the 
standard care in the United States is to verify pregnancy only by positive urine β-hcg at initial 
conception visit (ACOG, 2013; Youngkin, et al, 2013; Group health, 2013; United healthcare, 
n.d.), this is the definition that will be used in this paper. Therefore pregnancy is defined a 
positive urine β-hcg test confirmed in a healthcare setting. 
Theoretical Definition 
 Combining the above definitions, smoking cessation during pregnancy occurs when a 
patient who has a healthcare confirmed positive urine β-hcg and was a current smoker at 
conception who self-reported smoking 100 cigarettes in their life and had smoked at least once in 
the seven days prior to conception, has not taken even one puff of a cigarette in the previous 
seven days. 
Chapter 3: Methods and Framework 
Iowa Model 
 Theories and models within nursing provide a framework for conducting research and 
developing evidence based protocols. The Iowa Model was developed in 1994 by Marita Titler 
as a model to guide evaluation of current nursing practices as well as develop and implement 
new practices grounded in best evidence (Titler, Kleiber, & Steelman, 2001). Since its 
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introduction, the Iowa Model has been utilized across the country to successfully guide 
development of evidence based practice standards and protocols (Bergstrom, 2011; Haxton, 
Doering, Gingras, & Kelly, 2012; Hermes, Deakin, Lee, & Robinson, 2009; Kowal, 2010). This 
project will follow the Iowa Model which has six steps: select a topic, form a team, retrieve 
evidence, develop an evidence based practice protocol, implement the new practice, and finally 
evaluate the outcome. However, this project is focused on developing an evidence based practice 
protocol, thus will only be using steps one through four.  
Select a topic. As discussed above, this project will analyze research on assisting patients 
toward smoking cessation during pregnancy. The compilation of research will then be developed 
into an evidence based practice protocol.  The topic of smoking cessation during pregnancy is 
explored and formally defined above.  
Form a team. For this project a committee has been formed to guide research and 
development of the protocol. Dr. Angelia Mickle will chair the project committee and focus on 
overseeing and guiding project progression and implementation. Nurse Practitioner Carol Cooke 
has agreed to sit on this project committee and act as a liaison between research synthesis and 
practical implementation. She is a practitioner at Oak Creek OB/Gyn and will connect the 
academic research process to implementation where she practices.  
Evidence retrieval. Evidence retrieval will begin January 5
th
, 2015 and will conclude 
February 8
th
, 2015. During this time Academic Search Complete, CINAHL, Cochrane, 
Healthsource: Nursing/Academic, and Medline databases will all be searched using the terms 
“smoking cessation” and “pregnancy” for articles published since 2009. Websites of applicable 
governing agencies such as ACOG, American Academy of Pediatrics, and the CDC will also be 
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searched for guidelines and research. Retrieved research will be stored and organized using 
Mendeley reference manager.  
Developing an evidence based practice protocol. An evidence based practice protocol 
will be developed from the research and best evidence found during retrieval. This protocol will 
be developed for implementation at Oak Creek Ob/Gyn. Oak Creek is a primary care women’s 
health practice made up of three office locations in which ten providers practice including seven 
Physicians and three Nurse Practitioners. Committee member Carol Cooke practices within this 
group as a Nurse Practitioner and will help guide implementation. In order for implementation of 
any new protocol it is vital that all participating members are on board and find value in the new 
implementation. Therefore, the remaining nine practitioners in this group also are key players for 
implementation of this protocol. 
Chapter 4: Results 
Databases and Key Terms 
 During the research process, five databases were searched as well as two governing 
agencies. The databases included Academic Search Complete, CINAHL, Cochrane, 
Healthsource: Nursing/Academic, and Medline. ACOG and the CDC online websites and 
databases were searched as well. The search terms “smoking cessation” and “pregnancy” were 
used and the search was limited to articles published since 2009.  
Focus Areas  
Inclusion criteria. Literature was searched for research regarding three main areas: (1) 
understanding quitting and its barriers, (2) effects of quitting and cutting down, (3) ways to assist 
the patient to stop smoking during pregnancy. Inclusion criteria were established using these 
three focus areas. Assisting the patient to stop smoking during pregnancy was further divided 
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into three categories including behavioral intervention, nicotine replacement therapy, and 
medications.  
Exclusion criteria. Articles excluded from evaluation were articles evaluating relapse 
post-partum, smoking with psychiatric disorders, and smoking with other drug addictions. 
Anxiety and depression handled by primary care providers was not considered a psychiatric 
disorder and was evaluated in this study. Some descriptive research articles included other drug 
use as a descriptive variable while evaluating many variables. These studies were not specifically 
evaluating drugs during pregnancy and were included in the evaluation of literature.  
Findings 
 Research was grouped by above listed themes and formatted into a table for each 
theme. Findings in each of these core areas were summarized for discussion in this section. Each 
article was also summarized in tables below and level of evidence was identified. The level of 
evidence rating system used seven levels with level one being the strongest made up of 
systematic review (SR) of randomized controlled trials (RCT), level two includes articles from 
atleast one RCT, level three includes controlled trials without randomization, level four includes 
case control and cohort studies, level five includes SR of descriptive or qualitative studies, level 
six is made up of descriptive or qualitative studies, and level seven is expert opinion. This rating 
system has been used to develop nursing evidence based practice protocols and extensively in 
nursing literature (Melnyk & Fineout-Overholt, 2005; Dearholt & Dang, 2012).  
Understanding. After reviewing the literature, risk factors for smoking while pregnant 
included age (Masho et al, 2013), less than a high school education (Masho et al, 2013; Alford, 
Lappin, Peterson, & Johnson, 2009), unemployed, criminal history, social services involved, 
ETOH and drugs (Masho et al, 2013), smoking partner, high rate of tobacco consumption, 
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decreased or no pre-natal care, multiparous (Alford, Lappin, Peterson, & Johnson, 2009; 
Schneider, Huy, Schultz, & Diehl, 2010). Risk factors for prohibiting smoking cessation while 
pregnant were living with smoking partner, emotional distress (Hauge, Aarø,  Torgersen, & 
Vollrath, 2013) anxiety, depression, relationship discord, negative life events (Hauge, Torgerse, 
& Vollrath, 2012; Massey & Compton, 2013), and stress (Haskins et al, 2010; Holtrop, Meghea, 
Raffo, Biery, Chartkoff, & Roman, 2010), increased number of years between pregnancies 
(Hauge, Aarø,  Torgersen, & Vollrath, 2013), and heavy smoking/increased tobacco usage 
(20+/d) (Hauge, Aarø,  Torgersen, & Vollrath, 2013; Haskins et al, 2010).  Barriers cessation 
while pregnant included weight control, mood stabilization (Davies, 2012; Varescon, Leignel, 
Poulain, & Gerard, 2011), and prenatal depression (Orr, Blazer, & Orr, 2012). Factors that play a 
role in achieving cessation included being in an advanced stage of change due to pregnancy 
(Buja et al, 2011). Table 1 summarizes the findings of each research article in this category. 
 
Table 1: Understanding  
 Citation Title Level of 
Evidence 
Summary 
1 
U 
(Flemming, 
Graham, 
Heirs, Fox, 
& Sowden, 
2013) 
Smoking in Pregnancy: a 
Systematic Review of 
Qualitative Research of 
Women who Commence 
Pregnancy as Smokers 
V SR of 
qualitative 
research 
Four main themes emerged regarding women’s experiences of 
smoking during pregnancy. (1) Smoking was very embedded in 
women’s lives. (2) Women felt like they were questioned about 
smoking only because they were pregnant. (3) Many viewed 
cessation as quitting for pregnancy rather than for good. (4) 
Quitting had significant costs for the woman and cutting down 
was a positive alternative. 
2 
U 
(Hauge, 
Aarø,  
Torgersen, 
& Vollrath, 
2013) 
Smoking During 
Consecutive Pregnancies 
among Primiparous 
Women in the 
Population-Based 
Norwegian Mother and 
Child Cohort Study 
IV  cohort study Risk factors preventing smoking cessation included living with 
smoking partner, emotional distress, increased number of years 
between pregnancies, heavy smoking 
3 
U 
(Davies, 
2012) 
The Effect of Body 
Image and Mood on 
Smoking Cessation in 
Women.  
 V  SR of 
qualitative 
and 
quantitative 
research 
Many women use smoking as a way to control weight and 
stabilize their mood. 
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4 
U 
(Buja et al, 
2011) 
Socio-Demographic 
Factors and Processes 
Associated with Stages 
of Change for Smoking 
Cessation in Pregnant 
Versus Non-pregnant 
Women. 
IV descriptive 
study 
Pregnancy causes women to be at a more advanced stage of 
change and thus more open to smoking cessation counseling. 
5 
U 
(Masho et 
al, 2013) 
Least Explored Factors 
Associated with Prenatal 
Smoking 
 I
V 
cohort study Risk factors for smoking during pregnancy include age, less 
than a high school education, unemployed, criminal history, 
social services, alcohol or drug use. 
6 
U 
(Hauge, 
Torgerse, 
& Vollrath, 
2012) 
Associations Between 
Maternal Stress and 
Smoking: Findings from 
a Population-Based 
Prospective Cohort 
Study 
IV cohort study Anxiety, depression, relationship discord, and negative life 
events can decrease likelihood of smoking cessation. 
7 
U 
(Ferguson 
& Hansen, 
2012) 
 A Preliminary 
Examination of 
Cognitive Factors that 
Influence Interest in 
Quitting During 
Pregnancy 
VI descriptive Women are less likely to recognize risks to the fetus as a risk 
of smoking compared to risks to other body systems.  
8 
U 
(Schneider, 
Huy, 
Schultz, & 
Diehl, 
2010) 
Smoking Cessation 
During Pregnancy: A 
Systematic Literature 
Review 
II SR of RCT A smoking partner, a large number of children, a high rate of 
tobacco consumption, as well as deficiencies in prenatal care 
were predictors of smoking during pregnancy. 
9 
U 
(Holtrop, 
Meghea, 
Raffo, 
Biery, 
Chartkoff, 
& Roman, 
2010) 
Smoking Among 
Pregnant Women with 
Medicaid Insurance: Are 
Mental Health Factors 
Related? 
VI descriptive "Mental health history, stress, demographics, current alcohol 
and past drug use are all strongly related to continued smoking 
during pregnancy". 
10 
U 
(Massey & 
Compton, 
2013) 
 Psychological 
Differences Between 
Smokers Who 
Spontaneously Quit 
During Pregnancy and 
Those Who Do Not: A 
Review of Observational 
Studies and Directions 
for Future Research 
II SR of RCT Those with mental health histories are less likely to 
spontaneously quit smoking during pregnancy. 
11 
U 
(Alford, 
Lappin, 
Peterson, & 
Johnson 
2009) 
Pregnancy Associated 
Smoking Behavior and 
Six Year Postpartum 
Recall. 
VI descriptive "Mother’s education, asthma status, amount of pre-pregnancy 
smoking, gravidity, and father's smoking status were important 
in the prediction of pregnancy associated smoking." 
12 
U 
(Varesco, 
Leignel, 
Poulain, & 
Gerard, 
2011) 
Coping Strategies and 
Perceived Stress in 
Pregnant Smokers 
Seeking Help for 
Cessation 
IV case control Pregnant smokers attempting to quit report a higher level of 
anxiety and lower coping strategies. 
13 
 
13 
U 
(Wigginton 
& Lee, 
2013) 
Stigma and Hostility 
Towards Pregnant 
Smokers: Does 
Individuating 
Information Reduce the 
Effect? 
VI descriptive Perceptions of college students were more negative of smoking 
mothers.  
14 
U 
 
 
 
(Tombor, 
Urban, 
Berkes, & 
Demetrovic
s, 2010) 
Denial of Smoking-
Related Risk among 
Pregnant Smokers.  
 
 
IV 
 
 
 
 
cohort 
 
 
 
 
A higher level of risk denial seems to be one of the major 
determinants of women's smoking status during pregnancy. 
 
 
 
15 
U 
(Haskins et 
al, 2010) 
Correlates of Smoking 
Cessation at Pregnancy 
onset among Hispanic 
Women in 
Massachusetts 
IV cohort Women born outside the United States,  a family history of 
diabetes, and non-Puerto Rican Hispanics were more likely to 
quit smoking. Women with high stress, marijuana use, and 
parous women were less likely to quit. Women who smoked 
20+ cigarettes/d in pre-pregnancy were less likely to quit 
smoking compared with light smokers. Age, income, body 
mass index, language preference, pre-pregnancy exercise, and 
alcohol consumption were not associated with quitting. 
16 
U 
(Orr, 
Blazer, & 
Orr, 2012) 
Maternal Prenatal 
Depressive Symptoms, 
Nicotine Addiction, and 
Smoking-Related 
Knowledge, Attitudes, 
Beliefs, and Behaviors. 
VI descriptive Prenatal depressive symptoms may be a barrier to smoking 
cessation. 
(SR = systematic review; RCT = randomized controlled trial; U = category of understanding) 
 
Effects of stopping and cutting down on smoking. Literature consistently reported 
smoking cessation is the gold standard and first priority regarding tobacco exposure during 
pregnancy. Smoking cessation reduces chance of low birth weight and prematurity (Flower, 
Shawe, Stephenson, & Doyal, 2013). Cessation early in pregnancy is best. The literature supports 
the third trimester as the cutoff point for benefit. Cessation prior to third trimester increases 
weight, head circumference, and length (Bailey, McCook, Clements, & McGrady, 2011; 
Vardavas, 2010). One of the only negative effects of smoking cessation during pregnancy is it 
can cause pregnant women to gain more weight during pregnancy (Restall et al, 2014). 
Reducing smoking as a secondary option for those who fail complete cessation during 
pregnancy received mixed reviews. Reducing nicotine exposure during pregnancy can decrease 
preterm delivery (Bailey, McCook, Hodge, & McGrady, 2012) and increases birth weight 
(Flower, Shawe, Stephenson, & Doyal, 2013). However, Bengamin-Garner & Stotts (2013) 
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found although there was an increase in raw birth weight, differences were not statistically 
significant. Consensus throughout all of these articles remains the same. Smoking cessation 
should still be the gold standard. However, cutting down should be recognized as a second line 
alternative measure (Graham, Flemming, Fox, Heirs, & Sowden, 2014). Table two summarizes 
findings of each individual research article examining understanding quitting and cutting down. 
Table 2: Effects of Quitting and Cutting Down 
 Citation Title Level of 
Evidence 
Summary 
17 
E 
(Amash & 
Jaradeh, 
2012) 
Effect of Active and 
Passive smoking during 
Pregnancy on its 
Outcomes 
IV cohort study Statistically significant lower birth weight and lower apgar 
scores of those who smoked. 
18 
E 
(Flower, 
Shawe, 
Stephenson
, & Doyal, 
2013) 
Pregnancy Planning, 
Smoking Behaviour 
during Pregnancy, and 
Neonatal Outcome: UK 
Millennium Cohort 
Study 
IV cohort study This study grouped those who stopped smoking and those who 
reduced number of cigarettes together and was still significant 
that it reduced low birth weight and prematurity. 
19 
E 
(Bailey, 
McCook, 
Clements, 
& 
McGrady, 
2011) 
Quitting Smoking 
During Pregnancy and 
Birth Outcomes: 
Evidence of Gains 
Following Cessation by 
Third Trimester 
IV cohort study There is a significant improvement in weight and head 
circumference if quit prior to third trimester. 
20 
E 
(Restall et 
al, 2014) 
Risk Factors for 
Excessive Gestational 
Weight Gain in a 
Healthy, Nulliparous 
Cohort 
IV cohort study Women gain more weight when stop smoking during 
pregnancy which can act as a barrier to smoking cessation. 
21 
E 
(Vardavas, 
2010) 
Smoking and Smoking 
Cessation During Early 
Pregnancy and its Effect 
on Adverse Pregnancy 
Outcomes and Fetal 
Growth 
IV cohort study Smoking cessation during early pregnancy significantly 
increases birth weight, length, and head circumference. 
22 
E 
(Bengamin-
Garner & 
Stotts, 
2013) 
Impact of Smoking 
Exposure Change on 
Infant Birth Weight 
Among a Cohort of 
Women in Prenatal 
Smoking Cessation 
Study 
IV cohort study Although not statistically significant, the increase in infant 
birth weight associated with reduction from heavy to light 
exposure suggests potential for benefit. The only statistically 
significant comparison was between quitters and sustained 
heavy smokers, confirming that smoking cessation should 
remain the goal for pregnant women. 
23 
E 
(Bailey, 
McCook, 
Hodge, & 
McGrady, 
2012) 
Infant Birth Outcomes 
Among Substance Using 
Women: Why Quitting 
Smoking During 
Pregnancy is Just as 
Important as Illicit Drugs 
IV case control Smoking during pregnancy caused lower birth weight than 
illicit drug use. 
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24 
E 
(Seybold et 
al, 2012) 
 Smoking in Pregnancy 
in West Virginia: Does 
Cessation/Reduction 
Improve Perinatal 
Outcomes? 
IV cohort study Decreasing smoking reduces preterm deliveries 
25 
E 
(Graham, 
Flemming, 
Fox, Heirs, 
& Sowden, 
2014) 
 Cutting Down: Insights 
from Qualitative Studies 
of Smoking in 
Pregnancy 
V SR of 
qualitative 
research 
"Our findings suggest that cutting down in pregnancy, as an aid 
and an alternative to quitting require greater recognition of 
healthcare and tobacco control policies are to be sensitive to 
the perspectives and circumstances of smokers." 
 
Behavioral interventions. 
Theories. Two theories and one model were displayed in multiple studies throughout 
literature. The theory of planned behavior helps guide intervention development (Ben Natan, 
Golubev, & Shamrai, 2010). Using the transtheoretical model to guide intervention was more 
likely to assist patients to stop smoking (Aveyard et al, 2006). The model of the 5 A’s was 
widely supported throughout literature. ACOG uses this model to guide recommendations for 
smoking cessation during pregnancy. The 5 A’s include asking about smoking status, assess 
readiness to change, advise the pregnant patient about risks with smoking, assist her to stop 
smoking, and arrange follow up.  Using the 5 A’s has shown improvement in quit rates during 
pregnancy (Kim, England, Kendrick, Dietz, & Callaghan, 2009). However, as discussed above, 
usage of the 5 A’s is suboptimal. Because of this, current literature mostly examined how to 
increase utilization of the 5 A’s.  Having an established office intervention improved the “assist” 
stage of the 5A’s (Moss, Cluss, Watt-Morse, & Pike, 2009). Educating providers also improves 
utilization of 5A’s (Bowden, Oag, Smith, & Miller, 2010). 
Financial incentives. Throughout literature there was a high number of articles 
examining financial incentives role and efficacy in smoking cessation during pregnancy. 
Financial incentives were found to increase and prolong cessation rates (Ierfino et al, 2015; 
Donatell, 2000) They also increase program involvement and program success (Mantzari, Vogt, & 
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Marteau, 2012). A voucher system was shown to have improved birth outcomes (Higgins et al, 
2010). However, financial incentives had low acceptance rates among pregnant women (Lynagh, 
Bonevski, Symonds, & Sanson-Fisher, 2011). This was in part due to beliefs it would create 
inequalities, enhance or decrease motivation, and add stress to relationships (Thomson, Morgan, 
Crossland, Bauld, Dykes, & Hoddinot, 2014). 
Increasing access. Another common theme throughout literature regarding behavioral 
interventions for smoking cessation during pregnancy was increasing access to obstetric 
providers. This was hypothesized to help because there were many pregnant women who 
reported low to moderate awareness of effects of smoking during pregnancy (Levis et al, 2014). 
Many different programs were trialed in attempt to address this issue, however minimal success 
was documented.  Phone calls weekly from the providers’ office did not increase cessation rates 
compared to receiving a handout (Bullock, Everett,  Mullen, Geden, Longo, & Madsen; 2009). 
Motivational interviewing did not increase cessation rates (Hayes et al, 2013). Counseling did 
not provide large gains in cessation (Filion et al, 2011). Ultrasound feedback did not increase 
quit rates (Stotts et al, 2009). While many attempts were unsuccessful, there were a few 
programs able to successfully help pregnant smokers to quit. Community based pregnancy 
resource centers were found to successfully educate low income and help with successful 
quitting (Cluss, Levine, & Landsittel, 2011). Home visits were found to increase successful quit 
rates (Karatay, Kublay, & Emiroğlu, 2010; Fedall et al, 2012; Matone, O'Reilly, Xianqun, 
Localio, & Rubin, 2012) Video Doctor access which “delivered interactive tailored messages, an 
educational worksheet for participants, and a cuing sheet for providers at next visit” at baseline, 
1 month, and each prenatal care visit after one month did increase cessation rates (Tsoh, Kohn, & 
Gerbert, 2010). 
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Coping mechanisms. There were three main coping mechanisms found to increase 
smoking cessation during pregnancy. Yoga helped manage stress while quitting (Bock et al, 
2012). Exercise decreased craving and withdrawal symptoms (Harper, Fitzgeorge,Tritter, & 
Prapavessis, 2012). Partner support was found to have mixed reviews; two articles found it did 
not impact quit rates (Koshy, Mackenzie, Tappin, & Bauld, 2010; Hemsing, Greaves, O'Leary, 
Chan, & Okoli, 2012), while another article found it significantly increased quit rates (Donatell, 
2000). Table three summarizes the findings of individual research articles in the focus area of 
behavioral interventions. 
 
Table 3: Behavioral Interventions 
 Citation Title Level of 
Evidence 
Summary 
28 
B 
(Ben 
Natan, 
Golubev, & 
Shamrai, 
2010) 
 Smoking During Pregnancy: 
Analysis of Influencing 
Factors Using the Theory of 
Planned Behaviour 
VI descriptive Nursing interventions guided by the TPB constructs may 
help Israeli women quit smoking during pregnancy and 
reduce prevalence of smoking during pregnancy. 
29 
B 
(Levis et al, 
2014) 
Women’s Perspectives on 
Smoking and Pregnancy and 
Graphic Warning Labels 
VI descriptive Participants had low to moderate awareness of effects of 
smoking during pregnancy. Many believed it was okay to 
smoke during 1st trimester. Motivations to quit included 
risk-focused info especially about risk to baby and 
graphic warning labels with pictures. 
30 
B 
(Stotts et 
al, 2009) 
Ultrasound Feedback and 
Motivational Interviewing 
Targeting Smoking Cessation 
in the Second and Third 
Trimesters of Pregnancy.  
II RCT Ultrasound feedback with smoking effects on baby 
yielded no significant difference in quit rates. 
31 
B 
(Aveyard et 
al, 2006) 
 A Randomized Controlled 
Trial of Smoking Cessation 
for Pregnant Women to Test 
the Effect of a 
Transtheoretical Model-Based 
Intervention on Movement in 
Stage and Interaction with 
Baseline Stage. 
II RCT Transtheoretical model  based interventions are 
statistically more likely to assist patients to stop smoking. 
32 
B 
(Ierfino et 
al, 2015) 
Financial Incentives for 
Smoking Cessation in 
Pregnancy: a Single Arm 
Intervention Study Assessing 
Cessation and Gaming 
IV cohort study This study found there were higher prolonged cessation 
rates with financial incentives 
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33 
B 
 
 
 
(Tsoh, 
Kohn, & 
Gerbert, 
2010) 
 
Promoting Smoking Cessation 
in Pregnancy with Video 
Doctor Plus Provider Cueing: 
a Randomized trial 
 
II 
 
 
 
 
RCT 
 
 
 
 
The Video Doctor plus provider cueing is an efficacious 
adjunct to routine prenatal care by promoting provider 
advice and smoking reduction among pregnant smokers. 
 
 
34 
B 
(Moss, 
Cluss, 
Watt-
Morse, & 
Pike, 2009) 
Targeting Pregnant and 
Parental smokers: Long-term 
Outcomes of a Practice-Based 
Intervention 
IV cohort study Office interventions improved obstetric providers’ rates 
of “assist”. 
35 
B 
(Kim, 
England, 
Kendrick, 
Dietz, & 
Callaghan, 
2009) 
The Contribution of Clinic-
Based Interventions to Reduce 
Prenatal Smoking Prevalence 
among US Women 
IV cohort study 5 A's with 5-15 min of provider counseling and a self-
help handout decreased the smoking prevalence in late 
pregnancy from 16.4% to 15.6% 
36 
B 
(Mantzari, 
Vogt, & 
Marteau, 
2012) 
The Effectiveness of Financial 
Incentives for Smoking 
Cessation During Pregnancy: 
is it from Being paid or from 
the Extra Aid? 
III controlled 
trial without 
randomizati
on 
Woman receiving incentive for  involvement perceive 
significantly higher involvement and program success. 
37 
B 
(Harper, 
Fitzgeorge,
Tritter, & 
Prapavessis
, 2012) 
Acute Exercise Effects on 
Craving and Withdrawal 
Symptoms among Women 
Attempting to Quit Smoking 
Using Nicotine Replacement 
Therapy 
IV case control An acute bout of moderate intensity exercise can alleviate 
cravings as well as psychological and sedation 
withdrawal symptoms in quitters using NRT. 
38 
B 
(Lynagh, 
Bonevski, 
Symonds, 
& Sanson-
Fisher, 
2011) 
 Paying Women to Quit 
Smoking During Pregnancy? 
Acceptability Among 
Pregnant Women. 
VI descriptive Acceptability for the use of financial incentives in 
reducing antenatal smoking is low among pregnant 
women. 
39 
B 
(Bullock, 
Everett,  
Mullen, 
Geden, 
Longo, & 
Madsen; 
2009) 
Baby BEEP: a Randomized 
Controlled Trial of Nurses' 
Individualized Social Support 
for Poor Rural Pregnant 
Smokers. 
II RCT No significant difference between women who received 
weekly phone calls and those who received pamphlets 
40 
B 
(Thomson, 
Morgan, 
Crossland, 
Bauld, 
Dykes, & 
Hoddinot, 
2014) 
Unintended Consequences of 
Incentive Provision for 
Behavior Change and 
Maintenance around 
Childbirth 
VI descriptive "Financial incentives are controversial and generated 
emotive and oppositional responses." "Four key themes 
emerged: how incentives can address or create 
inequalities; enhance or diminish intrinsic motivation and 
wellbeing; have a positive or negative effect on 
relationships" 
41 
B 
(Tappin et 
al, 2015) 
Financial Incentives for 
Smoking Cessation in 
Pregnancy: RCT 
II RCT Significantly more women who received financial 
incentives stopped smoking.  
42 
B 
(Bowden, 
Oag, 
Smith, & 
Miller, 
2010) 
An Integrated Brief 
Intervention to Address 
Smoking in Pregnancy 
IV cohort Educating providers about 5A's and how to utilize 
increases their rate of 5A utiliation 
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43 
B 
(Filion et 
al, 2011) 
The effect of Smoking 
Cessation Counselling in 
Pregnant Women: a Meta-
Analysis of Randomized 
Controlled Trials. 
I SR of RCT “Available data from RCTs examining the isolated effect 
of smoking cessation counseling in pregnant woman are 
limited but sufficient to rule out large treatment effects. 
Future RCTs should examine pharmacological therapies 
in this population." 
44 
B 
(Koshy, 
Mackenzie, 
Tappin, & 
Bauld, 
2010) 
Smoking Cessation During 
Pregnancy: the Influence of 
Partners, Family and Friends 
on Quitters and Non-Quitters 
VI
I 
qualitative Close associates such as partners and support people vary 
in their support for the smoking woman attempting to 
quit. Future research needs to evaluate their role further. 
45 
B 
(Hemsing, 
Greaves, 
O'Leary, 
Chan, & 
Okoli, 
2012) 
Partner Support for Smoking 
Cessation During Pregnancy: a 
Systematic Review 
I SR of RCT Partner support was not found to have a significant 
impact on pregnant smoker quit rates. 
46 
B 
(Higgins et 
al, 2010) 
Effects of Smoking Cessation 
with Voucher-Based 
Contingency Management on 
Birth Outcomes 
II RCT These results provide evidence that smoking-cessation 
treatment with voucher-based CM may improve 
important birth outcomes. 
47 
B 
(Bock et al, 
2012) 
Yoga as a Complementary 
Treatment for Smoking 
Cessation in Women 
II RCT At 8 weeks, more women had stopped smoking in yoga 
group. It is thought to be because of stress control. 
48 
B 
(Hayes et 
al, 2013) 
Effectiveness of Motivational 
Interviewing in Influencing 
Smoking Cessation in 
Pregnant and Post-partum 
Disadvantaged Women 
IV cohort No significant difference between those who received 
motivational interviewing and those who did not. 
49 
B 
(Chang et 
al, 2013) 
Smoking Is Bad for Babies: 
Obstetric Care Providers' Use 
of Best Practice Smoking 
Cessation Counseling 
Techniques 
VI qualitative 5A's: 98% of providers asked, 21% performed  at least 
the first three A's, no providers did all 5 
50 
B 
(Naughton, 
Prevost, 
Gilbert, & 
Sutton, 
2012) 
Randomized Controlled Trial 
Evaluation of a Tailored 
Leaflet and SMS Text 
Message Self-help 
Intervention for Pregnant 
Smokers (MiQuit) 
II RCT MiQuit intervention group received a tailored handout 
and 11 week program of tailored text messages. 
Significantly more women stopped smoking in the 
control group and significantly more women had 
cognitive determinants to quit in the future. 
51 
B 
 
 
 
 
(Windsor et 
al, 2014) 
 
 
 
 
Effectiveness of the Smoking 
Cessation and Reduction in 
Pregnancy Treatment 
(SCRIPT) Dissemination 
Project: A Science to Prenatal 
Care Practice Partnership. 
III 
 
 
 
 
 
case control 
 
 
 
 
 
SCRIPT program included home visits and was 
significantly more likely to quit. 
 
 
 
 
52 
B 
(Naughton, 
Jamison, & 
Sutton, 
2013) 
Attitudes Towards SMS text 
Message Smoking Cessation 
Support: a Qualitative Study 
of Pregnant Smokers 
VI qualitative Text messaging helped most when it was personalized 
and convenient real-time intervention. 
53 
B 
(Hill et al, 
2013) 
Baby Be Smoke Free: 
Teenage Smoking Cessation 
Pilot. 
IV cohort study Technology may be best way to help pregnant teens stop 
smoking because they prefer to keep their smoking status 
a secret (stage of development?) 
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54 
B 
(Bombard 
et al, 2013) 
Telephone Smoking Cessation 
Quitline Use Among Pregnant 
and Non-pregnant Women 
IV cohort study Quitlines improved cessation rates. 
55 
B 
(Baxter, 
Everson-
Hock, 
Messina, 
Guillaume, 
Burrows, & 
Goyder; 
2010) 
Factors Relating to the Uptake 
of Interventions for Smoking 
Cessation among Pregnant 
Women: A Systematic Review 
and Qualitative Synthesis.  
 I SR of 
qualitative 
and 
quantitative 
literature 
"The review suggests a need for greater training in this 
area and the greater use of protocols. (p 685)" 
56 
B 
(Cluss, 
Levine, & 
Landsittel, 
2011) 
The Pittsburgh STOP 
Program: Disseminating an 
Evidence-Informed 
Intervention for Low-Income 
Pregnant Smokers.  
IV cohort study Community based pregnancy resource centers can 
successfully educate low income pregnant smokers on 
smoking risks during pregnancy. This can lead to 
smoking cessation. 
57 
B 
(Albrecht, 
Kelly-
Thomas, 
Osborne, & 
Ogbagabar, 
2011) 
The SUCCESS Program for 
Smoking Cessation for 
Pregnant Women 
IV cohort study Setting Universal Cessation Counseling Education and 
Screening Standards (SUCCESS) was developed as an 
evidence-based practice program which established a 
protocol for office use with intervention guides and 
successful increased quit rates. 
58 
B 
(Fujioka, 
Kobayashi 
& Turale, 
2012) 
Short-Term Behavioral 
Changes in Pregnant Women 
after a Quit-Smoking Program 
via E-Learning 
IV case control  E-learning program using cell phone internet connection 
to give support and advise to pregnant smokers 
successfully increased quit rates. 
59 
B 
(Karatay, 
Kublay, & 
Emiroğlu, 
2010) 
Effect of motivational 
interviewing on smoking 
cessation in pregnant women 
IV case control This is an example of a successful stop smoking program 
which included 8 home visits, 5 interventions based of 
transtheoretical model, and 3 follow up appointments.  
60 
B 
(Fedall et 
al, 2012) 
 Integrating a Clinical Model 
of Smoking Cessation into 
Antenatal Care. 
IV cohort study Midwife home visits and enlisting in formal smoking 
cessation program increased quit rates. 
61 
B 
 
 
(Tappin et 
al, 2010) 
 
 
Smoking Prevalence and 
Smoking Cessation Services 
for Pregnant Women in 
Scotland 
IV 
 
 
 
cohort study 
 
 
 
The US problem of poorly implemented plan is 
happening in other countries too (Scotland). 
 
 
62 
B 
(Donatell, 
2000) 
Randomized Controlled Trial 
Using Social Support and 
Financial Incentives for High 
Risk Pregnant Smokers: 
Significant Other Support 
(SOS) Program 
II RCT Monetary incentive and personal support person 
significantly increased quit rates. 
63 
B 
(Matone, 
O'Reilly, 
Xianqun, 
Localio,  & 
Rubin, 
2012) 
Home Visitation Program 
Effectiveness and the 
Influence of Community 
Behavioral Norms: a 
Propensity Score Matched 
Analysis of Prenatal Smoking 
Cessation 
IV cohort study Home visits increased rates of smoking cessation. 
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Nicotine replacement therapy. The United States Food and Drug Administration (FDA) 
has determined nicotine replacement therapy (NRT) to be category D (Nicotin, 2015). Because 
of this, providers within the United States do not generally prescribe NRT. However, European 
countries have approved NRT’s use in pregnancy; effectiveness and consequences of NRT have 
been extensively studied. Throughout literature, NRT has been found to decrease nicotine 
cravings and decrease fetal exposure to nicotine (Oncken, Campbell, Chan, Hatsukami, & 
Kransler, 2009). NRT has also been found to decrease low birth weight compared to smokers 
(Oncken & Kranzler, 2009; Lancaster, 2014; Forinash, Pitlick, Clark, & Alstat, 2010) and when 
studied there was no difference compared to active smokers (Coleman, Chamberlain, Davey, 
Cooper, & Leonardi-Bee, 2012). NRT also decreased prematurity compared to smokers 
(Forinash, Pitlick, Clark, & Alstat, 2010), and there was no difference compared to non-smokers 
(Coleman, Chamberlain, Davey, Cooper, & Leonardi-Bee, 2012). However, both of these results 
are only true if the mother stops smoking with NRT use. One study found that if the mother uses 
NRT and continues to smoke the risk of preterm delivery and small for gestational age double 
compared to non-smokers, whereas those who smoke without NRT use is only 1.31 times more 
likely to experience these effects as non-smokers (Gaither, Brunner Huber, Thompson, & Huet-
Hudson; 2009). There were three studies that evaluated NRT’s correlation with birth defects. All 
three studies found that NRT did not cause birth defects (Oncken & Kranzler, 2009; Coleman et 
al, 2012; Coleman, Chamberlain, Davey, Cooper, & Leonardi-Bee, 2012). However, of the five 
studies that evaluated NRT usage and quit rates, none of the five studies found a significant 
difference in quit rates when NRT was used at standard dosing (standard dosing means the same 
dosing used on non-pregnant adults). It is hypothesized that this is because maternal nicotine 
absorption decreases since some of the nicotine is transferred to the fetus. If this is true, 
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increased doses of nicotine replacement may lead to higher cessation rates. However, high dose 
NRT has not been studied for efficacy or safety profile. Table four summarizes the findings of 
individual research articles focusing on NRT. 
Table 4: NRT  
64 
N 
(Coleman, 
Chamberlai 
Cooper, & 
Leonardi-
Bee, 2011) 
 Efficacy and Safety of 
Nicotine Replacement Therapy 
for Smoking Cessation in 
Pregnancy: Systematic Review 
and Meta-Analysis 
I SR of 
RCT 
No statistical significance that NRT is any more or less safe 
nor is it more or less effective than standard practice. 
65 
N 
(Coleman 
et al, 2014) 
The SNAP Trial: A 
Randomized Placebo-
Controlled Trial of Nicotine 
Replacement Therapy in 
Pregnancy -- Clinical 
Effectiveness and Safety Until 
2 years After Delivery, with 
Economic Evaluation 
II RCT NRT use at standard dosing yielded no significant 
difference in smoking cessation rates.  2-year-olds born to 
women who used NRT were more likely to have survived 
without any developmental impairment. More research 
needed to evaluate higher doses 
66 
N 
(Gaither, 
Brunner 
Huber, 
Thompson, 
& Huet-
Hudson; 
2009) 
Does the Use of Nicotine 
Replacement Therapy During 
Pregnancy Affect Pregnancy 
Outcomes? 
I
V 
cohort 
study 
Women who use NRT and continue to smoke are at twice 
the risk of preterm delivery and small for gestational age as 
non-smokers. Those who smoke without NRT use are 1.31 
times more likely to deliver early and have babies small for 
gestational age. Thus, if NRT is used, the women must stop 
smoking. 
67 
N 
 
(Strandberg
-Larsen et 
al, 2008) 
Use of Nicotine Replacement 
Therapy During Pregnancy and 
Stillbirth: A Cohort Study 
I
V 
 
cohort 
study 
 
NRT not associated with still births. Smoking during 
pregnancy has higher rate of still births. 
 
68 
N 
(Brose, 
McEwen, 
& West, 
2013) 
Association Between Nicotine 
Replacement Therapy Use in 
Pregnancy and Smoking 
Cessation 
I
V 
cohort 
study 
"Combination NRT was associated with higher odds of 
quitting compared with no medication, whereas single NRT 
showed no benefit." 
69 
N 
(El-
Mohandes, 
2013) 
A Randomized Clinical Trial 
of Trans-Dermal Nicotine 
Replacement in Pregnant 
African-American Smokers. 
II RCT No significant difference between those who received NRT 
and cognitive behavioral therapy (CBT) and those who 
received CBT alone. 
70 
N 
(Oncken & 
Kranzler, 
2009) 
What do We Know about the 
Role of Pharmacotherapy for 
Smoking Cessation Before or 
During Pregnancy? 
I SR RCT NRT does not improve quit rates, but does increase birth 
weight and did not adversely affect birth outcomes. 
71 
N 
(Lancaster, 
2014) 
In Pregnant Smokers, the 
Nicotine Patch did not Increase 
Abstinence or Birthweight 
More than Placebo. 
II RCT In pregnant women who smoked, the 16-hour nicotine 
patch did not increase smoking abstinence or infant 
birthweight more than placebo. 
72 
N 
(Coleman 
et al, 2012) 
A Randomized Trial of 
Nicotine-Replacement Therapy 
Patches in Pregnancy 
II RCT No significant difference in smoking cessation or birth 
defects between those who received NRT patches and the 
control group. 
73 
N 
(Forinash, 
Pitlick, 
Clark, & 
Alstat, 2010) 
Nicotine Replacement Therapy 
Effect on Pregnancy Outcomes 
I SR NRT use significantly decreased the risk of preterm 
delivery and low birth weight compared to that of smokers. 
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74 
N 
(Dornelas, 
Oncken, 
Greene, 
Sankey, & 
Kranzler, 
2013) 
Major Depression and PTSD 
in Pregnant Smokers Enrolled 
in Nicotine Gum Treatment 
Trial. 
II RCT "Pregnant women with a history of MDD and PTSD appear 
to be as likely to benefit from smoking cessation treatment 
as those without such a history." 
75 
N 
(Oncken, 
Campbell, 
Chan, 
Hatsukami, 
& Kransler, 
2009) 
Effects of Nicotine Patch or 
Nasal Spray on Nicotine and 
Cotinine Concentrations in 
Pregnant Smokers. 
II RCT Daily, cigarette craving decreased more in the patch verses 
other groups. Nicotine patch and nasal spray reduce 
maternal nicotine exposure compared with smoking and 
may be effective for smoking cessation. 
76 
N 
(Coleman, 
Chamberlai
n, Davey, 
Cooper, & 
Leonardi-
Bee, 2012) 
Pharmacological Interventions 
for Promoting Smoking 
Cessation during Pregnancy 
I SR of 
RCT 
This SR found no studies examining buproprion or 
varenicline. No statistically significant difference was seen 
for smoking cessation in later pregnancy after using NRT as 
compared to control. There were no statistically significant 
differences in rates of miscarriage, stillbirth, premature 
birth, birthweight, low birthweight, admissions to neonatal 
intensive care or neonatal death between NRT or control 
groups. 
Medications. Outside of NRT there are two main pharmacologic therapies offered to 
non-pregnant adults that have been documented throughout literature as effective for smoking 
cessation assistance. Bupropion and varenicline are relied on extensively to successful assist 
smokers to stop smoking. However, neither of these medications are approved by the FDA for 
use in pregnancy. Very few studies have evaluated their safety and effectiveness.  
 Bupropion. Bupropion was originally developed for depression. It works to inhibit 
uptake of norepinephrine and dopamine by the neurons (Bupropion hydrochloride, 2015). Its 
mechanism of action for smoking cessation assistance is unknown, but is used widely within the 
United States and is approved by the FDA. However, it is pregnancy category C (Bupropion 
hydrochloride, 2015). One study evaluated Bupropion’s effects on the fetus (Chun-Fai-Chan et 
al, 2005). It found that no major malformations occurred. Babies were delivered at normal 
gestational age and normal birth weights (Chun-Fai-Chan et al, 2005). However, spontaneous 
abortions increased (20 spontaneous abortions in 136 live births). A study looking at bupropion 
effects on placentas after birth observed that bupropion did in fact cross the placenta, but 
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appeared to not impair placental functioning (Earhart, Patrikeeva, Wang, Reda Abdelrahman, 
Hankins, Ahmed, & Nanovskaya, 2010). 
 Varenicline. The other drug widely used by non-pregnant smokers wishing to stop 
smoking is varenicline which works by both agonizing and blocking nicotine receptors 
(Varenicline, 2015). There is only one observational study of a mother who used varenicline for 
four weeks while pregnant. Her baby was born at 38 weeks with no abnormalities (Kaplan, 
Dündar, Kasap, & Karadas; 2014). Even though varenicline has hardly been studied, it is 
estimated that one percent of women are exposed to varenicline during pregnancy accidentally. 
Because of this, Harrison-Woolrych, Paterson, and Tan, (2013), call for a registry of women 
exposed to varenicline during pregnancy to track drug efficacy and pregnancy outcomes. Table 
five outlines the articles covering medications for smoking cessation during pregnancy. 
Table 5: Medications 
79 
M 
(Chun-
Fai-Chan 
et al, 
2005). 
 Pregnancy Outcome of 
Women Exposed to 
Bupropion during 
Pregnancy: A Perspective 
Comparative Study 
I SR of 
RCT 
Bupropion exposure during pregnancy did not 
increase preterm delivery, small for gestational age, or 
malformations. It raised the rates of spontaneous 
abortion. Rates of spontaneous abortions are similar to 
the safety of antidepressants during pregnancy." 
80 
M 
(Harrison-
Woolrych, 
Paterson, 
& Tan, 
2013) 
Exposure to the Smoking 
Cessation Medicine 
Varenicline During 
Pregnancy: A Prospective 
Nationwide Cohort Study 
IV cohort 
study 
Approximately 1% of women of reproductive age 
prescribed varenicline may be exposed to this 
medicine during pregnancy. “This could result in 
significant fetal exposure worldwide and indicates the 
need for a global pregnancy register for varenicline.” 
81 
M 
(Kaplan, 
Dündar, 
Kasap, & 
Karadas; 
2014) 
Pregnancy Outcome after 
Varenicline Exposure in the 
First Trimester 
VI
I 
case 
report 
Mother used varenicline for 4 weeks and baby was 
born at 38 weeks with no anomalies. 
82 
M 
(Earhart, 
Patrikeeva
, Wang,  
Reda 
Abdelrah
man, 
Hankins, 
Ahmed, & 
Nanovska
ya, 2010) 
Transplacental Transfer and 
Metabolism of Bupropion 
IV case 
control 
Bupropion crosses the placenta, however does not 
affect placental functioning. These data suggest that 
bupropion has the potential of being used for smoking 
cessation during pregnancy and should be further 
investigated for its safety and efficacy. 
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Recommendations 
Four key recommendations with four sub-recommendations emerged from reviewed 
literature. Table six summarizes these recommendations. NRT therapy at standard doses did not 
yield cessation improvements. However, since nicotine crosses the placenta, a smaller percent is 
available to the mother. Therefore further research needs to evaluate higher doses of NRT for 
safety and efficacy. A varenicline registrar could benefit the progression of research in 
understanding the safety and efficacy of varenicline. Monetary incentives were the most 
effective non-pharmacologic intervention. This could be utilized by insurance companies to 
incentivize women to stop smoking while pregnant.  
Table 6: Recommendations 
Recommendation Strength  Corresponding Studies and Level of Evidence 
1) Future research 
studying high dose 
NRT 
Strong 43 (Filion et al, 2011) 
65 (Coleman et al, 2014)  
75 (Oncken, Campbell, Chan, Hatsukami, &     Kransler, 2009) 
I 
II 
II 
2) Establish a 
varenicline registrar 
Strong 43 (Filion et al, 2011) 
80 (Harrison-Woolrych, Paterson, & Tan, 2013) 
81 (Kaplan, Dündar, Kasap, & Karadas; 2014) 
I 
IV 
VII 
3) Monetary incentives Strong 41  (Tappin et al, 2015) 
46  (Higgins et al, 2010) 
62  (Donatelle, 2000) 
II 
II 
II 
4) Development and 
utilization of clinic 
based practice  
protocols  
Strong 39  (Bullock, Everett,  Mullen, Geden, Longo, & Madsen; 2009) 
55  (Baxter, Everson-Hock, Messina, Guillaume, Burrows, & Goyder; 
2010) 
57  (Albrecht, Kelly-Thomas, Osborne, & Ogbagabar, 2011) 
59  (Karatay, Kublay, & Emiroğlu, 2010) 
61  (Tappin et al, 2010) 
II 
I 
IV 
IV 
IV 
4. a) Use the 5 A’s to 
the full extent 
Moderate 33  (Tsoh, Kohn, & Gerbert, 2010) 
34  (Moss, Cluss, Watt-Morse, & Pike, 2009) 
35  (Kim, England, Kendrick, Dietz, & Callaghan, 2009) 
42  (Bowden, Oag, Smith, & Miller, 2010) 
49  (Chang et al, 2013) 
II 
IV 
IV 
IV 
VI 
4. b) Target pre-
conception visits 
Moderate 76  (Coleman, Chamberlain, Davey, Cooper, & Leonardi-Bee, 2012) I 
4. c) Recognize cutting 
down as 2
nd
 line  
Moderate 23  (Bailey, McCook, Hodge, & McGrady, 2012) 
24  (Seybold et al, 2012) 
25  (Graham, Flemming, Fox, Heirs, & Sowden, 2014) 
IV 
IV 
V 
4. d) Cessation before 
3
rd
 trimester 
Weak 19  (Bailey, McCook, Clements, & McGrady, 2011) IV 
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Evidence based practice protocol. In order to address the need for established protocols 
and interventions, an evidence based practice protocol was developed for implementation at an 
obstetric office in Southwest Ohio. This protocol uses the 5 A’s and starts with asking every 
gynecologic patient, regardless of pregnancy status, if they smoke. This allows for providers to 
target pre-conception patients for smoking cessation (recommendation 4b) From this question, 
providers follow the protocol algorithm (image 1) which leads to a provider hand out (image 2) 
which prompts the provider regarding what to discuss and key points to highlight. The protocol 
also utilizes a patient hand out (image 3). This handout is to be sent home with the pregnant 
smoking patient at every visit as a reminder of the goal and provides tips when they are no longer 
at the providers’ office. Both the provider hand out and patient hand out highlight 
recommendations 4c and 4d. 
Chapter 5: Discussion 
After a thorough search of the literature, there was no clearly effective and safe option for 
smoking cessation during pregnancy. Home visits were consistently effective at increasing 
smoking cessation rates, however, most of these studies utilized the Midwife system set up in 
Europe. Home visits may not be feasible in the current US healthcare system. Incentives such as 
monetary or voucher systems showed success. One drawback to these is perceived stress on 
relationships and emotional status that women reported (Thomson, Morgan, Crossland, Bauld, 
Dykes, & Hoddinott, 2014). Utilization of the 5A’s framework leads to increased cessation rates 
if fully utilized. At this time, no pharmacologic options including NRT, Bupropion, and 
varenicline have been found both safe and effective. For these reasons it is best to target smoking 
women before they are pregnant in order to attain highest smoke free pregnancy rates. As the 
protocol shows, pre-family planning visits are key visits for providers to emphasize that stopping 
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smoking is a must prior to pregnancy. At this stage, medications can be used safely with greater 
efficacy. If a woman is already pregnant and still smoking the priority should be to stop before 
reaching the third trimester. Complete cessation of smoking early in pregnancy is the gold 
standard and best goal. However, for woman who cannot stop, decreasing nicotine exposure 
should be recognized as second line. The goal of cutting down on cigarettes early in pregnancy is 
to ultimately stop smoking by the third trimester. However, even if smoking is never completely 
stopped, research has shown that cutting down improves fetal outcomes. To continue addressing 
this problem, more clinics need to implement evidence based practice protocols. 
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Figure 1: Evidence Based Practice Protocol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1) Ask: Is the patient smoking? 
No 
Yes 
Is the patient pregnant? 
Yes 
No 
1st or 2nd Trimester 
3rd Trimester 
Goal: smoke free by 28 weeks 
2) Provider hand out  
3)Listen to patient questions and 
concerns, discuss barriers and 
coping mechanisms. 
4) Set goal and formal plan 
together, give patient hand out 2 
5) Follow up in 1 month 
Goal: stop smoking ASAP! 
2) Provider hand out  
3) Listen to questions and concerns, discuss 
barriers and coping mechanism. 
4) Set goal and formal plan, give patient hand 
out 1 
5) Follow up in 2 week 
Good job! Stay 
smoke free! 
No 
Planning to 
conceive?  
Yes 
Goal: smoke free prior to conception 
2) Provider hand out  
3) Assess patient readiness 
4) Aggressively manage smoking cessation with 
lifestyle and pharmacologic intervention 
5) Follow up at next regularly scheduled visit 
and PRN with questions 
2) Provider hand out  
3) Assess patient 
readiness 
4) Patient hand out 4, 
offer pharmacologic 
intervention 
5) Follow up  yearly 
Based off of the 5A’s:   
1) Ask 
2) Advise 
3) Assess 
4) Assist 
5) Arrange  
29 
 
Figure 2: Provider Handout 
What to Tell Your Patients About 
Smoking and Pregnancy 
 
Complications during Pregnancy 
Smoking during pregnancy can cause intrauterine growth 
restriction leading to small for gestational age. It can also 
cause pre-term delivery. 
 
 
Complications after Delivery 
Smoking during pregnancy can cause your baby to have 
more apnea episodes immediately after delivery, can 
cause asthma as a child and into adulthood, and can 
decrease growth from delivery through puberty.  
 
Goals of Quitting 
Quitting before the third trimester significantly decreases 
damage to the placenta and fetus. No nicotine during 
pregnancy is the goal, but cutting down can also reduce 
the damage to placenta and fetus. Before the third 
trimester, discuss importance of 100% cessation prior to 
28 weeks. If in 3rd trimester stress importance of 
minimizing exposure starting now! 
 
Coping Mechanisms 
Stress/emotions and habit are two of the hardest parts of 
stopping smoking. Remove cigarettes and ash trays from 
view. Remove triggers and stay away from situations that 
make you want to smoke. Think through relaxation 
techniques that you can use as coping mechanisms. Many 
find benefit from yoga, exercise, and talking with 
supportive people in your life.  
 
Resources for Quitting:  
ACOG: A Clinician’s Guide to Helping Pregnant Women Quit Smoking 
http://www.acog.org/-/media/Departments/Tobacco-Alcohol-and-Substance-Abuse/SCDP.pdf? 
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Figure 3: Patient Handout 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stopping Smoking can Help Your Baby be Healthy! 
Smoking during pregnancy can cause 
preterm delivery, decreased weight and 
size, new born apnea episodes, 
childhood asthma, and many other 
complications.  
Coping mechanisms can make your 
stopping smoking journey a little easier 
Coping Mechanisms 
Yoga, Exercise, Talking with a close friend 
or partner, Getting outside, message. 
1) Make a plan 
2) Tell family and friends your plan 
3) Plan for challenges and prepare coping skills 
4) Remove and avoid triggers 
5) Talk to your obstetric provider 
Ready to Quit?  
These tips can help! 
Resources to help you stay smoke free: smokefree.gov, 
women.smokefree.gov and the smoke free women app, 1-
800-QUIT-NOW  
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